Authors


Kennedy Ferruggia

Latest:

Leveraging AI to Reduce Breast Cancer Risk

Mikael Eriksson, PhD, epidemiologist at Karolinska Institute in Sweden, discusses the development and implementation of an artificial intelligence (AI) model to reduce bias and improve breast cancer prevention.


Erin Naomi Hahn, MPH

Latest:

What Value Do Teaching Hospitals Provide Commercial Beneficiaries When in an ACO?

Accountable care organizations (ACOs) with a major teaching hospital were associated with lower mortality, lower inpatient spending, lower emergency department utilization, and higher overall outpatient spending.


Michael Tunkelrott, MBA

Latest:

Population-Based Return on Investment of Deploying Transient Elastography

Deploying vibration-controlled transient elastography/controlled attenuation parameter devices at the population level is a financially advantageous solution to address the epidemic of fatty liver disease.


Julie Hobson

Latest:

Appropriate ED Utilization Leading to Better Care Coordination

Addressing avoidable emergency department (ED) utilization takes interventions in partnership with providers.



Ashleigh Watson, MD

Latest:

The Persistent Pandemic of Violence Against Health Care Workers

The problem of violence against health care workers has escalated across the world, and tackling this issue requires the support of administrators.


Joselyne E. Aucapina

Latest:

Building Research Capacity in Primary Care Practices That Serve Predominantly Racial and Ethnic Minority Populations

The successful collaboration between a primary care–based network of practices and academic researchers demonstrates feasibility and the need for more funding for primary care research.


Melanie T. Turk, PhD, RN

Latest:

Stakeholder Analysis: Medicare Diabetes Prevention Program Awareness and Implementation

This article describes facilitators of and barriers to uptake of the underutilized Medicare Diabetes Prevention Program from the perspectives of health care providers and program suppliers in western Pennsylvania.


Sarah Shetler, PharmD, MPH

Latest:

Medication Adherence Star Ratings Measures, Health Care Resource Utilization, and Cost

For patients prescribed diabetes, hypertension, and hyperlipidemia medications, nonadherence to CMS Star Ratings quality measures of medication adherence was associated with increased health care resource utilization and costs.


Neil Goldfarb, BA

Latest:

Estimating the Economic Burden of Migraine on US Employers

The Migraine Impact Model is an interactive calculator that estimates migraine prevalence within a workforce and the associated economic burden of migraine on the employer.


Paul S. Appelbaum, MD

Latest:

Reimbursement for Genetic Variant Reinterpretation: Five Questions Payers Should Ask

Periodic reinterpretation of genetic sequencing results presents a challenge for developing transparent and systematic coverage and reimbursement policies.


Chelsea Cooper, PharmD

Latest:

Cost of Home vs Clinic Administration of Paclitaxel in Metastatic Breast Cancer

Home administration of oral paclitaxel and encequidar is associated with potential cost savings for payers compared with clinic administration of intravenous chemotherapy in metastatic breast cancer patients.


Madeleine K. Kanaley, BA

Latest:

Guideline-Informed Care Among Medicaid-Enrolled Children With Food Allergy

This article describes food allergy–related service utilization and identifies factors associated with guideline-informed care among Medicaid-enrolled US children with food allergy.


Jacob P. Klimek, PhD

Latest:

Impact of Including Drug Spending in Oncology Alternative Payment Models

This study demonstrates a method for understanding the effects of drug spending in the design of alternative payment models.


Marion Schauf, Dipl-Kff

Latest:

Budget Impact Analysis of Biosimilar Natalizumab in the US

Projected savings from biosimilar natalizumab were $452,611 over 3 years, driven by decreased drug acquisition costs and a utilization shift from reference to biosimilar natalizumab.


Laurel Buchanan, MA

Latest:

Accountable Care Organizations and HPV Vaccine Uptake: A Multilevel Analysis

The authors evaluated whether adolescents receiving care at accountable care organizations (ACOs) vs non-ACOs were more likely to initiate and complete the human papillomavirus (HPV) vaccination series.


Hrant Jamgochian

Latest:

Contributor: Medicare Policy Proposal Jeopardizes Care for Those on Dialysis

CEOs of 3 kidney care organizations explain flaws in CMS' recent reimbursement proposal.



Jeremy Wigginton, MD

Latest:

Lp(a) and Getting a Head Start Against Heart Disease: Jeremy Wigginton, MD

Lipoprotein a (Lp[a]) is a valuable tool for assessing a patient's risk of cardiovascular disease, which can facilitate earlier intervention efforts and reduce health care costs, argued Jeremy Wigginton, MD.


Alison E. Cuellar, PhD

Latest:

Addressing the Opioid Crisis

The authors highlight the diversity of multiagency electronic data-sharing approaches and present a case study addressing the opioid crisis


Leigh Maria Ramos-Platt, MD | image credit: chla.org
Leigh Maria Ramos-Platt, MD

Latest:

Building Community and Advancing Care at MDA 2025

One of the major highlights of the Muscular Dystrophy Association (MDA) Clinical & Scientific Conference is that invaluable networking opportunities can help clinicians elevate their own best practices.


Brittany Craiglow, MD, FAAD

Latest:

Pediatric Alopecia Areata Treatment With Baricitinib, Combination Therapies, Patient Adherence

In an interview with Brittany Craiglow, MD, FAAD, dermatologist at Dermatology Physicians of Connecticut in Fairfield, she advocates for combination therapies using baricitinib to treat pediatric alopecia areata and highlights the need for personalized treatment approaches based on Janus kinase inhibitor responses.


Naim Alkhouri, MD

Latest:

New Hope and Persistent Challenges for MASH Treatment: Naim Alkhouri, MD

Recent advances have marked a turning point for the treatment noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH), with more therapies on the horizon to hopefully better address patients' cirrhosis, explained Naim Alkhouri, MD.


Xinming Xie, PhD

Latest:

Determinants of ICS Therapy Adherence in Patients With Asthma

This study describes determinants affecting disease control and inhaled glucocorticosteroid therapy adherence for patients with asthma in western China.


Hannah Clarke

Latest:

AUA 2024: Disrupting the Field of Urology

Speakers at the 2024 American Urological Association (AUA) annual meeting highlighted the innovations and advancements that are pushing the field of urology forward.


Adam Colborn, JD

Latest:

Legislative Updates Shaping Managed Care Pharmacy: Adam Colborn, JD

Adam Colborn, JD, associate vice president for congressional affairs, Academy of Managed Care Pharmacy, highlights key policy updates that are impacting managed care pharmacy.


Michael Butzner, MPH

Latest:

Adverse Drug Effects Across Patients With Heart Failure: A Systematic Review

This systematic literature review reports incidence of adverse drug effects associated with guideline-directed medical therapy for patients with heart failure with reduced ejection fraction.


H. Joanna Jiang, PhD

Latest:

Medicare Advantage in Rural Areas: Implications for Hospital Sustainability

This retrospective cohort study of rural hospitals found that Medicare Advantage penetration increased substantially from 2008 to 2019 and was associated with greater hospital sustainability.


Bonnie A. Labdi, PharmD, BCOP

Latest:

Rituximab Reference vs Biosimilar Utilization for Oncology vs Nononcology Indications

Reporting on the real-world utilization of reference rituximab and its biosimilars can help show prescribing habits and reveal cost-saving opportunities.


Sheila M. Manemann, MPH

Latest:

Patient-Centered Communication and Outcomes in Heart Failure

Among community patients living with heart failure, excellent and good patient-centered communication was associated with a reduced risk of death.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo